Form 4 for NEO NEOGENOMICS INC
Accepted 2026-04-03 16:38:47 ET · period of report 2026-04-01 · accession 0001628280-26-023689 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-03 16:38 | 2026-04-01 | NEO | Zook Anthony P. | CEO, Dir | M - OptEx | $0.00 | +140.5K | 178.6K | +369% | $0 |
| D | 2026-04-03 16:38 | 2026-04-01 | NEO | Zook Anthony P. | CEO, Dir | F - Tax | $0.00 | -45.5K | 133.1K | -25% | $0 |
| D | 2026-04-03 16:38 | 2026-04-01 | NEO | Zook Anthony P. | CEO, Dir | M - OptEx | $0.00 | -140.5K | 281.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | M | A | 140,498 | $0.00 | 178,564 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-01 | F | D | 45,453 | $0.00 | 133,111 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-04-01 | M | D | 140,498 | $0.00 | 280,998 | D | $0.00 · — to — | 140,498 Common Stock | (F1) On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. (F2) Once vested, the shares of common stock are not subject to expiration. |